In the News
Aster Insights Names Dr. Anand Shah as Chief Executive Officer
Aster Insights has announced the appointment of Dr. Anand Shah as chief executive officer, effective immediately. He succeeds Jim Gabriele, who has stepped down from his position. Gabriele and Shah have collaborated closely on a number of strategic, operational, and business development initiatives over the past six...
Komodo Health unveils MapEnhance, a new centralized network of specialty data partners
Komodo Health has recently launched MapEnhance, a feature that leverages a network of specialty data partners connecting into the company’s platform. MapEnhance builds on Komodo’s Healthcare Map, which it characterizes as a de-identified data set on 330 million patients in the United States, by combining it with data...
Twist Bioscience and Aster Insights Partner on Launch of Next Generation Oncology Panel for Cancer Research
Twist Bioscience Corporation, a company that offers high-quality synthetic DNA using its silicon platform, along with Aster Insights, has announced the availability of the AsterExome panel, which can simultaneously enable whole exome sequencing (WES) with additional coverage for target regions known to contain 620...
Clinical ink Announces New Continuous Glucose Monitoring Solution
Clinical Ink, a global life science technology company, now offers continuous glucose monitoring (CGM) within its integrated digital biomarker solution. The new modules enable remote collection, central storage, and analysis of sensor data from commercially available devices for use in diabetes clinical trials. The...
RCT-DUPLICATE Findings Demonstrate Capability of Real-World Evidence Studies to Reach Conclusions Similar to Randomized Clinical Trials
Real-world evidence (RWE) technology and analytics company Aetion has announced the culmination of the RCT-DUPLICATE demonstration project, with complete findings published in The Journal of the American Medical Association (JAMA). This three-year initiative tested whether researchers asking clinical questions in...
Inside the new world of healthcare data
In a recent episode of the PharmaPhorum podcast, Evidation co-CEO and Executive Chair of the Board Deborah Kilpatrick discussed healthcare data collection in 2023 and how it intersects with stakeholders across the ecosystem, from tech and pharma companies to research participants. The discussion began with data...
Replica Analytics unveils Replica Synthesis 3.0
Replica Analytics, an Aetion company, has released Replica Synthesis 3.0, its privacy- and utility-preserving synthetic data generation software that has been updated with an enhanced user experience. This makes it easier for analysts to train generative models and evaluate their utility and privacy. The company...
M2GEN Rebrands to Aster Insights
Bioinformatics company M2GEN has announced that it is rebranding, changing its name to Aster Insights. As the nexus between patients, researchers, and the life sciences industry, the company’s unique clinical and molecular dataset has enabled new insights for researchers and accelerated target identification and drug...
Through reverse auctions, Minnesota pushes for PBM savings and price transparency
Truveris has helped the State of Minnesota save more than $28 million in pharmacy benefits expenses over the next two years. Using the company’s technology, the state was able to evaluate bids from competing pharmacy benefit managers (PBMs). Truveris’ technology allows health plan sponsors to conduct reverse...
Matternet Tests Longest Drone Delivery Route Between Hospitals and Labs in Switzerland
Matternet has begun test operations on a 5-kilometer (3-mile) beyond visual line of sight (BVLOS) drone delivery route over Zurich, Switzerland. This is the longest urban drone delivery route ever, and it still takes only seven minutes for drones to go from one facility to the other—a much shorter time than it would...
Press Releases
Montage Health Selects Xealth to Drive Digital Health Strategy
Montage Health, a California-based non-profit network, announced on Tuesday that it has chosen the Xealth digital health platform as its new primary medical system. Known for its prominent role in the digital health space, Xealth provides a variety of services to its...
Reimagine Care Welcomes Dan Nardi, Healthcare Industry Leader, as New CEO
Reimagine Care has announced that Dan Nardi will serve as its new Chief Executive Officer, effective July 10, 2023. Nardi replaces co-founder Dr. Aaron Gerber as CEO. Previously, Nardi served as Carrum Health’s Chief Operating Officer and Livongo’s Vice President of...
Clinical ink Appoints Andrew Kraus as Chief Technology Officer
Clinical Ink, a global life science technology company, has announced the appointment of Andrew Kraus as chief technology officer. In this role, Kraus will lead the development of the company’s expanding technology portfolio to support clinical trials. Kraus is an...
McKesson Ventures’ Dave Schulte Named One of Healthcare’s Top 25 Investors
McKesson Ventures Managing Director Dave Schulte has been recognized by GrowthCap as one of the top 25 healthcare investors for 2023. This award acknowledges healthcare investors who have demonstrated high levels of sustained investment performance and who are...
Koneksa Announces Partnership with Beacon Biosignals for Clinical Trials in Sleep and Neurologic Disorders Using EEG Biomarkers
Koneksa has announced a partnership with Beacon Biosignals, a computational neurodiagnostics company, to launch a clinical trial to investigate the integration of Beacon’s at-home electroencephalogram (EEG) into the Koneksa Neuroscience Solution Toolkit. The Beacon...